ES2172549T3 - Nuevas sales por adicion de acidos de cefem, cristalinas, y procedimiento para su preparacion. - Google Patents

Nuevas sales por adicion de acidos de cefem, cristalinas, y procedimiento para su preparacion.

Info

Publication number
ES2172549T3
ES2172549T3 ES95117409T ES95117409T ES2172549T3 ES 2172549 T3 ES2172549 T3 ES 2172549T3 ES 95117409 T ES95117409 T ES 95117409T ES 95117409 T ES95117409 T ES 95117409T ES 2172549 T3 ES2172549 T3 ES 2172549T3
Authority
ES
Spain
Prior art keywords
cefem
crystals
acids
procedure
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95117409T
Other languages
English (en)
Inventor
Rudolf Dr Lattrell
Walter Dr Durckheimer
Peter Dr Schmid
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis Deutschland GmbH
Original Assignee
Aventis Pharma Deutschland GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Deutschland GmbH filed Critical Aventis Pharma Deutschland GmbH
Application granted granted Critical
Publication of ES2172549T3 publication Critical patent/ES2172549T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/48—Methylene radicals, substituted by hetero rings
    • C07D501/56—Methylene radicals, substituted by hetero rings with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

COMPUESTOS DE LA FORMULA I DONDE N ES IGUAL A 1 O 2 Y M ES 0,4 - 2,6 Y DONDE X SIGNIFICA EL ANION DE UN ACIDO CARBOXILICO, MOSTRANDO UNA ACTIVIDAD ANTIBACTERIAL.
ES95117409T 1994-11-10 1995-11-06 Nuevas sales por adicion de acidos de cefem, cristalinas, y procedimiento para su preparacion. Expired - Lifetime ES2172549T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4440141A DE4440141A1 (de) 1994-11-10 1994-11-10 Neue kristalline Cephem-Säureadditionssalze und Verfahren zu ihrer Herstellung

Publications (1)

Publication Number Publication Date
ES2172549T3 true ES2172549T3 (es) 2002-10-01

Family

ID=6532953

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95117409T Expired - Lifetime ES2172549T3 (es) 1994-11-10 1995-11-06 Nuevas sales por adicion de acidos de cefem, cristalinas, y procedimiento para su preparacion.

Country Status (28)

Country Link
US (1) US5747484A (es)
EP (1) EP0711774B1 (es)
JP (1) JP3920939B2 (es)
KR (1) KR100449191B1 (es)
CN (1) CN1066452C (es)
AR (1) AR002246A1 (es)
AT (1) ATE213248T1 (es)
AU (1) AU707730B2 (es)
BR (1) BR9505132A (es)
CA (1) CA2162530C (es)
CZ (1) CZ290936B6 (es)
DE (2) DE4440141A1 (es)
DK (1) DK0711774T3 (es)
ES (1) ES2172549T3 (es)
FI (1) FI120263B (es)
HU (1) HU219475B (es)
IL (1) IL115914A (es)
MA (1) MA23709A1 (es)
NO (1) NO311891B1 (es)
NZ (1) NZ280424A (es)
OA (1) OA10242A (es)
PL (1) PL182806B1 (es)
PT (1) PT711774E (es)
RU (1) RU2161619C2 (es)
SK (1) SK282545B6 (es)
TR (1) TR199501392A2 (es)
TW (1) TW422847B (es)
ZA (1) ZA959510B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2288199A1 (en) * 1997-04-29 1998-11-05 The University Of New Mexico Hydroxynaphthoic acids and derivatives
PL208585B1 (pl) * 2002-10-25 2011-05-31 Intervet Int Bv Kompozycja farmaceutyczna o przedłużonym uwalnianiu zawierająca cefquinom, sposób jej wytwarzania i zastosowanie cefquinomu
CA2626273C (en) * 2005-10-29 2013-05-14 Intervet International Bv Cefquinome compositions and methods of their use
TWI400243B (zh) * 2009-07-20 2013-07-01 Intervet Int Bv 製造西喹諾（ｃｅｆｑｕｉｎｏｍｅ）粒子的方法
WO2013036783A2 (en) 2011-09-09 2013-03-14 Cubist Pharmaceuticals, Inc. Methods for treating intrapulmonary infections
US20140234365A1 (en) * 2011-09-29 2014-08-21 Alere San Diego, Inc. 2-hydroxyhippuric acid analogs, and methods for their synthesis and use
US8809314B1 (en) 2012-09-07 2014-08-19 Cubist Pharmacueticals, Inc. Cephalosporin compound
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
CN110279698B (zh) 2013-03-15 2022-10-28 默沙东有限责任公司 头孢特咯瓒抗生素组合物
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
US9320740B2 (en) 2013-03-15 2016-04-26 Merck Sharp & Dohme Corp. Ceftolozane-tazobactam pharmaceutical compositions
EP3043797B1 (en) 2013-09-09 2020-04-08 Merck Sharp & Dohme Corp. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US20150094293A1 (en) 2013-09-27 2015-04-02 Calixa Therapeutics, Inc. Solid forms of ceftolozane

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3118732A1 (de) * 1981-05-12 1982-12-02 Hoechst Ag, 6000 Frankfurt Cephalosporinderivate und verfahren zu ihrer herstellung
DE3248281A1 (de) * 1982-12-28 1984-06-28 Hoechst Ag, 6230 Frankfurt Kristalisierte cephem-saeureadditionssalze und verfahren zu ihrer herstellung
DE3316797A1 (de) * 1983-05-07 1984-11-08 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von cephemverbindungen
JPH064643B2 (ja) * 1985-12-20 1994-01-19 ファイザー製薬株式会社 セフアロスポリン化合物
DE3706020A1 (de) * 1987-02-25 1988-09-08 Hoechst Ag Kristallisierte cephem-saeureadditionssalze und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
NO954511L (no) 1996-05-13
AU3772895A (en) 1996-05-16
JP3920939B2 (ja) 2007-05-30
MA23709A1 (fr) 1996-07-01
FI955382L (fi) 1996-05-11
DK0711774T3 (da) 2002-04-22
AR002246A1 (es) 1998-03-11
FI955382A0 (fi) 1995-11-08
NO311891B1 (no) 2002-02-11
DE59510048D1 (de) 2002-03-21
IL115914A0 (en) 1996-01-31
ZA959510B (en) 1996-05-28
RU2161619C2 (ru) 2001-01-10
NZ280424A (en) 1997-06-24
US5747484A (en) 1998-05-05
TR199501392A2 (tr) 1996-07-21
JPH08208662A (ja) 1996-08-13
DE4440141A1 (de) 1996-05-15
EP0711774A1 (de) 1996-05-15
HU219475B (hu) 2001-04-28
AU707730B2 (en) 1999-07-15
PT711774E (pt) 2002-07-31
HU9503213D0 (en) 1996-01-29
PL311326A1 (en) 1996-05-13
SK139795A3 (en) 1996-06-05
CZ293395A3 (en) 1996-05-15
OA10242A (fr) 1997-09-19
FI120263B (fi) 2009-08-31
PL182806B1 (pl) 2002-03-29
ATE213248T1 (de) 2002-02-15
KR960017670A (ko) 1996-06-17
BR9505132A (pt) 1997-09-09
NO954511D0 (no) 1995-11-09
HUT74163A (en) 1996-11-28
CA2162530C (en) 2007-07-31
CN1066452C (zh) 2001-05-30
IL115914A (en) 2002-08-14
KR100449191B1 (ko) 2006-01-12
EP0711774B1 (de) 2002-02-13
CN1129220A (zh) 1996-08-21
CA2162530A1 (en) 1996-05-11
SK282545B6 (sk) 2002-10-08
TW422847B (en) 2001-02-21
CZ290936B6 (cs) 2002-11-13

Similar Documents

Publication Publication Date Title
ES2172549T3 (es) Nuevas sales por adicion de acidos de cefem, cristalinas, y procedimiento para su preparacion.
ES2063093T3 (es) Composiciones orales.
ES8104300A1 (es) Un procedimiento para la preparacion de nuevos bis-esteres de metanodiol.
ES2018111A6 (es) Procedimiento de preparacion de derivados de 4h-1-benzopiran-4-ona o sus sales.
ES8103753A1 (es) Procedimiento para la preparacion de acidos 3-cefem-4-carbo-xilicos sustituidos en la posicion 7
KR950700258A (ko) 레티노이드 수용체(rar)에 결합하는 헤테로고리 탄산유도체(heterocyclic carbonic acid derivatives which bind to retinoid receptors(rar))
DE69737605D1 (de) Sulfonierte aminosäurederivate und metalloproteinase-inhibitoren, die diese enthalten
ES2038251T3 (es) Un procedimiento para producir un derivado de benzamida.
CU22305A3 (es) Procedimiento para la preparacion de un derivado de aminoacidos
ES2070660B1 (es) Un procedimiento para la preparacion de 2,5-damino-3-hidroxihexanos sustituidos, utiles como inhibidores de proteasas retrovirales.
ES2130209T3 (es) Procedimiento para la obtencion y empleo de polisuccinimida, acido poliarparaginico y sus sales.
FR2395263A1 (fr) Derives d'acides thiadiazole-1, 2, 3 carboxyliques-5 utilisables comme matieres actives de produits herbicides
SE8005890L (sv) Salter av (+)-katekin, deras framstellning och anvendning, och kompositioner innehallande dessa salter
ES556746A0 (es) Un procedimiento para la preparacion de acidos 3-hidroxifenoxialquilenheterociclilcarboxilicos.
DE3665711D1 (de) Novel guanidinomethylbenzoic acid derivatives
ES2053856T3 (es) Derivados del acido 4-quinoleino carboxilico utiles para el tratamiento de enfermedades de la piel y del muco-epitelio.
PT1303267E (pt) Sistema de aplicacao dermico para o acido aminolevulinico
ES8707245A1 (es) Un metodo para preparar nuevos derivados de cefem
CO4290351A1 (es) Proceso
ES2117132T3 (es) Sales de desferrioxamina-b y su uso como queladores de hierro eficaces por via oral.
ES2167100T3 (es) Sales impregnadas, un procedimiento para su obtencion, y su empleo.
NO162722C (no) Fremgangsmaate for fremstilling av 6-alfa-monobrom-penicillansyre-1,1-dioksyd-derivater.
ES8201169A1 (es) Un procedimiento para la preparacion de derivados de quina- zolina
SE8001689L (sv) 6-beta-substituerade penicillansyror med beta-laktamas-inhibitorverkan
ES535624A0 (es) Un procedimiento para la preparacion de 9-deoxo-9a-metil-9a-aza-9a-homoeritromicina b o una sal de la misma

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 711774

Country of ref document: ES